GSE179667 NVP-BEZ235 U-87MG Uppsala 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179667_NVP-BEZ235_U-87MG Uppsala_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179667_NVP-BEZ235_U-87MG Uppsala_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179667_NVP-BEZ235_U-87MG Uppsala_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179667_NVP-BEZ235_U-87MG Uppsala_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

C-X-C motif chemokine ligand 8

Gene

chitinase 3 like 1

Gene

adhesion molecule with Ig like domain 2

Gene

brain expressed X-linked 1

Gene

transforming growth factor beta induced

Gene

serine peptidase inhibitor Kazal type 1

Gene

galectin 3 binding protein

Gene

complement C3

Gene

G protein-coupled receptor class C group 5 member A

Gene

stanniocalcin 2

  • Gene

    C-X-C motif chemokine ligand 8


  • Gene

    chitinase 3 like 1


  • Gene

    adhesion molecule with Ig like domain 2


  • Gene

    brain expressed X-linked 1


  • Gene

    transforming growth factor beta induced


  • Gene

    serine peptidase inhibitor Kazal type 1


  • Gene

    galectin 3 binding protein



  • Gene

    G protein-coupled receptor class C group 5 member A


  • Gene

    stanniocalcin 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.